Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches

Author(s): Molina CA

Abstract

Background and purpose:Arterial recanalization and subsequent reperfusion have extensively demonstrated their ability to restore the brain function when performed shortly after acute ischemic stroke. However, arterial recanalization does not necessarily lead to brain tissue reperfusion.

Summary of report:This review provides an update of current approaches to improve the efficacy profile of brain tissue reperfusion within and beyond the therapeutic window, including the use of novel thrombolytic agents, bridging intravenous and intra-arterial therapies, and mechanical clot retrieval or aspiration.

Conclusions:There are still several challenges in the near future of reperfusion therapy for acute ischemic stroke, such as improving the ultra-early access to treatment within the "golden hour," extending the therapeutic window beyond the current 4.5-hour time window, and developing novel thrombolitics or combined approaches to improve treatment efficacy.

Similar Articles

Ischemic stroke subtypes: a population-based study of incidence and risk factors

Author(s): Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, et al.

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence

Author(s): Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, et al.

Thrombolysis with alteplase 3 to 4

Author(s): Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al.

The science of stroke: mechanisms in search of treatments

Author(s): Moskowitz MA, Lo EH, Iadecola C

von Willebrand factor: an emerging target in stroke therapy

Author(s): De Meyer SF, Stoll G, Wagner DD, Kleinschnitz C

Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins

Author(s): André P, Denis CV, Ware J, Saffaripour S, Hynes RO, et al.

Shear-dependent changes in the three-dimensional structure of human von Willebrand factor

Author(s): Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, et al.

Deficiency of von Willebrand factor protects mice from ischemic stroke

Author(s): Kleinschnitz C, De Meyer SF, Schwarz T, Austinat M, Vanhoorelbeke K, et al.

Tissue plasminogen activator reduces neurological damage after cerebral embolism

Author(s): Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA

Tissue plasminogen activator

Author(s): Zivin JA, Lyden PD, DeGirolami U, Kochhar A, Mazzarella V, et al.

Quantal bioassay and stroke

Author(s): Zivin JA, Waud DR

Neuroprotective effects of anesthetic agents

Author(s): Kawaguchi M, Furuya H, Patel PM